Latest News About - Immunodiagnostic

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, July 12, 2020

3:07:00 AM CEST

Subscribe
RSS | MAP
Subscribe
subscribe | manage
Subscribe
current page | all pages
Subscribe
info | definition

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Norman Sharpless wrote: "Clearly, postponing procedures and deferring care as a result of the pandemic was prudent at one time, but the spread, duration, and future peaks of Covid remain unclear," "However, ignoring life-threatening non–Covid-19 conditions such as cancer for too long may turn one public health crisis into many others" External link

forbes Friday, July 10, 2020 4:43:00 PM CEST

Markus Seeger said: "The global research community has been working at unprecedented speeds to fight COVID-19," External link

markets-businessinsider Wednesday, July 8, 2020 1:23:00 PM CEST

Douglas Bryant said: “Our second quarter was even stronger than we had expected, driven by demand for our COVID-19 Molecular Diagnostics and Rapid Immunoassay products. With the rapid development, EUA clearance, and production of over 3 million Lyra SARS-CoV-2 and Lyra Direct SARS-CoV-2 assays, Quidel played a small, but important role in helping our high complexity lab customers with their SARS-2 PCR testing needs,” External link

4-traders Monday, July 6, 2020 11:14:00 PM CEST

Douglas Bryant added (about Supply Chain): “We witnessed strong execution on all fronts, with significant contributions from our R&D, Clinical, Regulatory, Supply Chain, Quality, Manufacturing, and Commercial organizations. I am proud to lead an organization that demonstrated extraordinary dedication, selflessness, and sacrifice during these challenging times,” External link

4-traders Monday, July 6, 2020 11:14:00 PM CEST

Enrico Ferrazzi spiega: “Per rispondere concretamente all’emergenza, la nostra struttura sanitaria si è duplicata. Dal primo marzo, infatti, abbiamo creato due cliniche ben distinte: una è dedicata alle donne non contagiate e una per quelle positive all’infezione” External link

mianews Monday, July 6, 2020 5:26:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.

Most active sources for this category

prnewswire

pr-inside

finanznachrichten-en

marketwatch

biomedcentral

4-traders

businesswire

7thspace

ema

newsmedical